Private equity firm KKR & Co. Inc. has invested $250 million in Henry Schein Inc., Long Island’s largest publicly traded ...
In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with ...
KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s ...
Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...
KKR plans to announce a deal that includes increasing its stake to 12% with the option to buy up to an additional 2.9% in the ...
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
Henry Schein said it expects to report earnings and revenue growth in the fourth quarter and forecast further gains in 2025 adjusted earnings, even as it confirmed an activist-investment deal with ...
The Melville, New York-headquartered firm has operations in 33 countries and provides medical supplies to more than 1 million customers. Henry Schein on Wednesday reported preliminary annual ...